Forte Biosciences
在场
Forte Biosciences 是一家在股票代码 FBRX (US) 下上市的公司。
高管
查看带有其 12 名主要高管的组织结构图
Forte Biosciences 搜索最多的简介
- Paul Wagner, Chief Executive Officer, President and Chairman of th...
- Stephen Doberstein, Director
- Steven Kornfeld, Director
创建提醒
跟踪 Forte Biosciences 的高管变动
生物技术
Forte Biosciences 拥有 2,330 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Nuvig Therapeutics 刚刚宣布为 161 筹款数百万美元。 (公布2024十二月5号).
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Forte Biosciences 的最新新闻稿
- Forte Biosciences to Host R&D Day December 3, 2024
- Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
- Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
- Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
- Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
- Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
- Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
- Forte Biosciences Inc - Investor Relations - News
- Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
- Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
- View more press releases Close
通过电子邮件
